NEW WHITE PAPER:  Solving Atypical Protein Expression with Transposase Technology    Dive in today!
Contact Us
Contact Us

Press Releases

Find the latest news on AGC Biologics partnerships, product approvals, site expansions, leadership updates, new programs, and more.

Microbial

2 min read

AGC Biologics Expands to Fill-Finish in U.S. Through Strategic Partnership with Pyramid Pharma Services

June 30, 2026 at 9:00 AM
Mammalian & mAbs Press Release Business Updates Microbial
Read press release

2 min read

AGC Biologics to Manufacture Teikoku Seiyaku's rhMMP-7 Drug Substance

May 25, 2026 at 5:00 PM
Press Release Tech Transfer Microbial
Read press release

2 min read

AGC Biologics Seattle site now certified to manufacture biologics for largest pharmaceutical market in South America

February 3, 2026 at 8:00 AM
Mammalian & mAbs Press Release Business Updates Microbial
Read press release
Seattle site team member hard at work

2 min read

Seattle Facility Achieves Regulatory Approvals, Customer Satisfaction and Zero-Finding ISO Certification Inspection

September 10, 2025 at 8:00 AM
Mammalian & mAbs Press Release Business Updates Microbial
Read press release

1 min read

AGC Biologics’ Heidelberg Site Supplies Drug Substance for Phase II Studies of Valneva’s Tetravalent Shigella Vaccine Candidate

July 29, 2025 at 7:00 AM
Press Release Microbial
Read press release

1 min read

AGC Biologics Honored at CDMO Leadership Awards for Excellence in Quality, Biologics and Cell and Gene Therapies

March 10, 2025 at 2:41 PM
Cell & Gene Therapy Mammalian & mAbs Press Release Microbial
Read press release
Seattle BLAs - 3 approvals in 2024

1 min read

AGC Biologics Seattle Achieves Approval for all 2024 Biologics License Applications from U.S. Food and Drug Administration, Concluding Pre-License Inspection

October 17, 2024 at 3:00 AM
Mammalian & mAbs Press Release Business Updates Microbial
Read press release
CompleCure and AGC Biologics Chiba Project Announcement

2 min read

CompleCure Partners with AGC Biologics’ Chiba Site to Develop Advanced Anti-Cancer Therapeutic Using Pioneering AMDC Technology

September 23, 2024 at 4:45 AM
Press Release Process Development Microbial
Read press release
NEC Bio Therapeutics and AGC Biologics Announce Collaboration to Manufacture Personalized Cancer Vaccines

2 min read

NEC Bio Therapeutics and AGC Biologics Announce Collaboration to Manufacture Personalized Cancer Vaccines

August 7, 2024 at 7:02 PM
Press Release Business Updates Microbial
Read press release
AGC Biologics is partnering with BioConnection to simplify the path to DP for biologics projects.

2 min read

AGC Biologics and BioConnection Partner to Offer New End-to-End Biopharmaceutical Drug Substance and Drug Product Development and Manufacturing Offering

May 22, 2024 at 3:00 AM
Mammalian & mAbs Press Release Business Updates Microbial
Read press release
1 2 Next